52% ORR per mIWG criteria, including 83% ORR for patients receiving 100 mg BID 88% ORR per PPR criteria, including 100% ORR for patients receiving 100 mg BID Median time to response 2.2 months with median duration of response and median PFS not yet reached
Fri, 25 Apr 2025 05:22:00 GMT Cogent announced that Ray Frost has joined Cogent as Senior Vice President, Market Access and Adam Boyd, Ph.D. has joined Cogent as Senior Vice ...
Fri, 25 Apr 2025 05:08:00 GMT All posters will be available on the ‘Posters and Publications’ page of Cogent’s website. New Leadership Appointments Cogent also announced today that Ray Frost has joined Cogent as Senior Vice ...
Fri, 25 Apr 2025 05:08:00 GMT April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq ... remains employed through each such vesting date. This press release contains forward-looking statements within the meaning ...
Wed, 16 Apr 2025 07:03:05 GMT We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Cogent Biosciences Inc. (NASDAQ:COGT) stands ...
Fri, 04 Apr 2025 15:00:00 GMT WASHINGTON, April 4, 2025 /PRNewswire/ -- Cogent Communications Holdings, Inc. (NASDAQ: CCOI) (the "Company" or "Cogent") today announced that a special-purpose, bankruptcy remote, indirect wholly ...